Anna Prestwich, MSN, ACNP
- Assistant in Surgery
Anna Prestwich, MSN, ACNP
- Assistant in Surgery
anna.prestwich@vumc.org
Research Program
Research Description
Tonna McCutcheon, APRN, MSN, BSN, DNP
- Assistant in Surgery
Tonna McCutcheon, APRN, MSN, BSN, DNP
- Assistant in Surgery
tonna.mccutcheon@vumc.org
Research Program
Research Description
Alexander Hawkins, M.D., M.P.H.
- Associate Professor of Surgery
Alexander Hawkins, M.D., M.P.H.
- Associate Professor of Surgery
alex.hawkins@vumc.org
Research Program
Research Description
Michael Hopkins, M.D.
- Associate Professor of Surgery
Michael Hopkins, M.D.
- Associate Professor of Surgery
ben.hopkins@vumc.org
Research Program
Research Description
Sophoclis Alexopoulos, M.D.
- Chief, Hepatobiliary Surgery and Liver Transplantation
- Associate Professor of Surgery
Sophoclis Alexopoulos, M.D.
- Chief, Hepatobiliary Surgery and Liver Transplantation
- Associate Professor of Surgery
sopho.alexopoulos@vumc.org
Research Program
Research Description
Theresa Sberna, M.P.H.
- Chief Business Officer
- Deputy Director for Strategy and Analytics
Phone
Vanderbilt-Ingram Cancer Center
691 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232
691 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232
Theresa Sberna, M.P.H.
- Chief Business Officer
- Deputy Director for Strategy and Analytics
(615) 875-8720
theresa.sberna@vumc.org
Vanderbilt-Ingram Cancer Center
691 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232
691 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232
Research Program
Rebecca J. Selove, Ph.D., M.P.H.
- Research Associate Professor (Tennessee State University)
- Adjunct Associate Professor of Psychiatry and Behavioral Sciences (Vanderbilt University)
Phone
Tennessee State University
Center for Prevention Research
3500 John A. Merritt Blvd.
Nashville, TN 37209
Center for Prevention Research
3500 John A. Merritt Blvd.
Nashville, TN 37209
Rebecca J. Selove, Ph.D., M.P.H.
- Research Associate Professor (Tennessee State University)
- Adjunct Associate Professor of Psychiatry and Behavioral Sciences (Vanderbilt University)
(615) 963-2558
rebecca.selove@vanderbilt.edu
Tennessee State University
Center for Prevention Research
3500 John A. Merritt Blvd.
Nashville, TN 37209
Center for Prevention Research
3500 John A. Merritt Blvd.
Nashville, TN 37209
Research Program
Difluoromethylornithine (DFMO) will be used in an open label, single agent, multicenter, study for patients with neuroblastoma in remission. In this study subjects will receive 730 Days of oral difluoromethylornithine (DFMO) at a dose of 750 mg/m2 250 mg/m2 BID (strata 1, 2, 3, and 4) OR 2500 mg/m2 BID (stratum 1B) on each day of study. This study will focus on the use of DFMO in high risk neuroblastoma patients that are in remission as a strategy to prevent recurrence.
